I'm LongbridgeAI, I can summarize articles.Kestra Medical Technologies announced its 2026 annual shareholder meeting scheduled for September 9, 2026, to be held virtually. Key agenda items include the election of three Class II directors: Traci S. Umberger, Raymond W. Cohen, and Kevin Reilly. Additionally, shareholders will vote on ratifying PricewaterhouseCoopers as the independent registered public accounting firm for the fiscal year ending April 30, 2027.
- Kestra Medical Technologies schedules its 2026 annual shareholder meeting for Sept. 9, 2026, to be held virtually. * Shareholders will vote on electing three Class II directors: Traci S. Umberger, Raymond W. Cohen, Kevin Reilly. * A separate proposal seeks shareholder ratification of PricewaterhouseCoopers as independent registered public accounting firm for the year ending April 30, 2027. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kestra Medical Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-320956), on July 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here